FDA Approved: INGREZZA SPRINKLE — Original Application (Neurocrine Biosciences, Inc.)

View source ↗

Summary

FDA approves INGREZZA SPRINKLE (valbenazine) via an original application for the treatment of tardive dyskinesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• INGREZZA SPRINKLE (valbenazine)

Snippet

ORIG AP for INGREZZA SPRINKLE (VALBENAZINE)